Contact Us

821 Alexander Rd #204
Princeton, NJ 08540
USA
Company Contact
Leeann Essai
NA Head of Marketing
609-480-9850
leeann.essai@guerbet.com
PR Agency Contact
Meghan Bianco
Taft Communications
meghan@taftcommunication...

More »

Guerbet is a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. A pioneer for more than 90 years in the field of contrast media with over 2,800 people globally, Guerbet is continuously innovating with 9% of revenue dedicated to Research & Development and four centers in France, Israel and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €817 million in revenue in 2019. For more information about Guerbet, please visit www.guerbet.com.

News Releases
Nov 20, 2020

Guerbet (GBT) a global leader in medical imaging, will host an on-demand session in the Innovation Theater during RSNA 2020. WHERE: Join the meeting through the RSNA virtual booth at...

Nov 20, 2020

Guerbet (GBT) a global leader in medical imaging, will demonstrate its product portfolio during a highlights demonstration at RSNA 2020. WHERE: Join the meeting through the RSNA virtual booth at...

Nov 12, 2020

Guerbet (GBT) a global leader in medical imaging, announced today that it will highlight UNIK, a tailored solution for diagnostic imaging, at the 2020 annual meeting of the Radiological Society of...

Apr 21, 2020

Princeton, N.J. – April 21, 2020 Guerbet (GBT), a global leader in medical imaging, announced today that it received FDA approval to manufacture Dotarem® (gadoterate meglumine) injection at its...

Mar 9, 2020

LOS ANGELES, MARCH 09, 2020 -- The American Board of Artificial Intelligence in Medicine (ABAIM) is pleased to announce its recent incorporation as a not-for-profit entity. The ABAIM plans to...

More »